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Background: The aim of our study was to determine the impact of vascular access on
in-hospital major bleeding (IHMB), particularly in acute coronary syndrome (ACS)
patients with moderate- to very high-bleeding risk.
Methods: We analyzed 995 ACS patients with the Can Rapid risk stratification of
Unstable angina patients Suppress ADverse outcomes with Early implementation of the
ACC/AHA guidelines (CRUSADE) moderate- to very high-bleeding risk scores in
trans-radial intervention (TRI) retrospective registry from 16 centers in Korea. 402
patients received TRI (TRI group) and 593 patients trans-femoral intervention (TFI
group). The Primary end-point was IHMB as defined in the CRUSADE.
Results: The use of 600mg loading dose of clopidogrel and low molecular weight heparin
were more common in TRI, however, the use of unfractionated heparin and glycoprotein
IIb/IIIa inhibitors were more common and hematocrit, creatinine clearance, blood
pressure and heart rate at admission were lower in TFI. TRI had lower incidences of
IHMB and blood transfusion than TFI (6.0% vs. 9.4%, p0.048; 4.5% vs. 9.4%,
p0.003). The patients suffered from IHMB had higher incidences of in-hospital and
1-year mortality than those free from IHMB (3.1% vs. 15.0%, p0.001; 7.2% vs. 30.0%,
p0.001). TRI was an independent predictor of IHMB (odds ratio: 0.305; 95%
confidence interval: 0.109-0.851; p0.003).
Conclusions: IHMB is still significantly correlated with in-hospital and 1-year mortality.
Our study suggests that compared to TFI, TRI could reduce IHMB in ACS with the
moderate- to very high-bleeding risk.
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Background: Contrast-induced nephropathy (CIN) is the major cause of hospital-
acquired renal failure. Although the efficacy of sodium bicarbonate to prevent CIN was
reported, long-term cardiovascular and renal outcome is unclear.
Methods: Between May 2006 and March 2010, 161 patients of multicenter with CKD
(Scr 1.2 mg/dl) who underwent cardiac catheterization were prospectively randomized
to receive short infusion of sodium bicarbonate (n80, 3ml/kg/h for 1h before, then
1ml/kg/h for 6h after procedure) or long infusion of 0.9% saline (n81, 1ml/kg/h for 12 h
before and for 12 h after procedure). Primary endpoint is the incidence of CIN defined
increase Scr more than 0.5mg/dl or 25% within 48 hours after procedure. Secondary
endpoint was cardiovascular and renal outcome 1 year after procedure.
Results: Two groups were well matched for baseline characteristics without age,
hypertension. The incidence of CIN was not different between 2 group (bicarbonate 8.8%
vs saline 2.5%, p0.10), One-year follow-up was completed with 124 patients (95%).
The change of %Cr and estimated GFR were not different in two groups (Cr 0.200.62
mg/dl vs 0.250.63 mg/dl, p0.67 : eGFR -2.78.8 vs -4.88.1 p0.12). No significant
difference was observed in two groups about the composite cardiovascular event and the
composite renal event.
Conclusions: Short infusion of sodium bicarbonate has almost similar effects on
incidence of CIN and long-term cardiovascular and renal outcome compared with the
standard saline infusion.
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Background: HAS-BLED score predicts bleeding risk in patients with atrial fibrilla-
tion.We have simplified the risk score and assessed its validity in a contemporary cohort
of patients who underwent percutaneous coronary intervention (PCI).
Methods: The study included 1851 consecutive patients undergoing PCI between
January 2010 and March 2012.We simplified the HAS-BLED score to BLEEDRS score
using routinely collected variables(Bleeding history,Low hemoglobin,Elderly,Elevated
BP, Drugs, Renal disease,Stroke).We assessed major bleeding events as per NCDR
definition.
Results: The median patient age was 65 years and 66% were male.Transfemoral access
was used in 83% and primary PCI was performed in 24.4% of the patients.Peri-procedural
antiplatelet and anticoagulation therapy included:aspirin(97%), clopidogrel(57%), prasu-
grel(37%), bivaluridin(32%), enoxaparin(9%), GPIIb/IIIa inhibitor(21%) and hepa-
rin(52%). The median BLEEDRS score was 2(0-6). We divided the patients into tertiles:
BLEEDRS (1)score2; BLEEDRS (2)score2 and5; BLEEDRS (3)score5. 5.1%
of the entire cohort of patients developed in-hospital bleeding events, 1.7% in BLEEDRS
(1),9.6% in BLEEDRS (2), and 20% in BLEEDRS (3)(P0.001). The BLEEDRS levels
were an independent determinant of bleeding after adjusting for gender, antiplatelet and
anticoagulation agents (P0.05). The calibration of the BLEEDRS score was good
(Hosmer-Lemeshow, P0.5), and its discriminatory capacity was acceptable, with an area
under the ROC curve of 0.75 (95% CI:0.71–0.79) (Figure-1)
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